| scholarly article | Q13442814 |
| P50 | author | Anthony H. Aletras | Q40337773 |
| Peter Kellman | Q87774572 | ||
| Andrew E Arai | Q95267900 | ||
| P2093 | author name string | W Patricia Ingkanisorn | |
| Kenneth L Rhoads | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gadolinium | Q1832 |
| circulatory system | Q11068 | ||
| myocardial infarction | Q12152 | ||
| P304 | page(s) | 2253-2259 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction | |
| P478 | volume | 43 |
| Q36222473 | A CMR study of the effects of tissue edema and necrosis on left ventricular dyssynchrony in acute myocardial infarction: implications for cardiac resynchronization therapy |
| Q40701837 | A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes |
| Q30475186 | ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents |
| Q57736172 | ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents |
| Q36971128 | Advances in clinical applications of cardiovascular magnetic resonance imaging |
| Q57761241 | Animal Models of Tissue Characterization of Area at Risk, Edema and Fibrosis |
| Q89462488 | Aortic Stiffness and Infarct Healing in Survivors of Acute ST-Segment-Elevation Myocardial Infarction |
| Q38081156 | Assessing myocardial recovery following ST-segment elevation myocardial infarction: short- and long-term perspectives using cardiovascular magnetic resonance |
| Q28387402 | Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance |
| Q37287520 | Assessment of myocardial viability with delayed-enhancement MRI in coronary artery disease: A correlative study with coronary artery stenosis using digital subtraction angiography |
| Q40127504 | Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction |
| Q35737105 | Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant |
| Q47191457 | C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction |
| Q88979559 | Can thrombectomy and catheters used increase angiographically visible distal embolization in ST elevation myocardial infarction? |
| Q38106499 | Cardiac MRI of acute coronary syndrome |
| Q38263089 | Cardiac MRI: a central prognostic tool in myocardial fibrosis |
| Q30446453 | Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction |
| Q38206247 | Cardiac magnetic resonance for prognostic assessment: present applications and future directions |
| Q80488538 | Cardiac magnetic resonance imaging: an essential diagnostic aid in suspected myocardial re-infarction in a 40 year old woman |
| Q47383987 | Cardiac troponin T and creatine kinase predict mid-term infarct size and left ventricular function after acute myocardial infarction: a cardiac MR study. |
| Q36969090 | Cardiovascular magnetic resonance for the clinical cardiologist |
| Q30432814 | Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies |
| Q47196867 | Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with ST-segment elevation myocardial infarction |
| Q45073081 | Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death |
| Q26998774 | Clinical and research applications of simultaneous positron emission tomography and MRI |
| Q40827334 | Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation m |
| Q82450085 | Comparison of magnetic resonance imaging findings in non-ST-segment elevation versus ST-segment elevation myocardial infarction patients undergoing early invasive intervention |
| Q37278781 | Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction |
| Q36457860 | Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside |
| Q37074696 | Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability |
| Q79991562 | Delayed-contrast enhancement cardioresonance in transient left ventricular apical ballooning |
| Q34992842 | Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index |
| Q48863298 | Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy |
| Q38126089 | Emerging concepts for myocardial late gadolinium enhancement MRI. |
| Q82050897 | Evaluating Microvascular Obstruction After Acute Myocardial Infarction Using Cardiac Magnetic Resonance Imaging and 201-Thallium and 99m-Technetium Pyrophosphate Scintigraphy |
| Q47270854 | Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study |
| Q33980680 | First-pass perfusion CMR two days after infarction predicts severity of functional impairment six weeks later in the rat heart |
| Q42571665 | Gadolinium can depict area at risk and myocardial infarction: a double-edged sword? |
| Q48745225 | Global and regional longitudinal strain assessed by two-dimensional speckle tracking echocardiography identifies early myocardial dysfunction and transmural extent of myocardial scar in patients with acute ST elevation myocardial infarction and rela |
| Q43952152 | Head-to-head comparison of 1 week versus 6 months CMR-derived infarct size for prediction of late events after STEMI. |
| Q100503900 | Hydrojet-based delivery of footprint-free iPSC-derived cardiomyocytes into porcine myocardium |
| Q37425560 | Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). |
| Q36237173 | Infarct healing is a dynamic process following acute myocardial infarction. |
| Q41430925 | Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarction |
| Q51235287 | Late gadolinium enhancement in the assessment of the infarcted mouse heart: a longitudinal comparison with manganese-enhanced MRI. |
| Q53150784 | Late gadolinium enhancement magnetic resonance imaging for the assessment of myocardial infarction: comparison of image quality between single and double doses of contrast agents. |
| Q53586110 | Lateral MI Explains the Presence of Prominent R Wave (R ≥ S) in V1. |
| Q54369363 | Long-term outcomes in patients with restrictive filling following ST-segment elevation myocardial infarction. |
| Q37812993 | MRI in acute myocardial infarction |
| Q37912854 | Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage |
| Q37154775 | Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back |
| Q36384512 | Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study |
| Q35149077 | Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction |
| Q36836016 | Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis. |
| Q35038983 | Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis |
| Q41333072 | Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MI. |
| Q34554094 | Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling |
| Q47296720 | Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion |
| Q34147112 | Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. |
| Q37133859 | Permanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine model |
| Q38117307 | Postconditioning in patients treated with primary percutaneous coronary intervention: an updated meta-analysis |
| Q36760564 | Prognosis following acute myocardial infarction: insights from cardiovascular magnetic resonance |
| Q36323087 | Prognostic Value of Troponin I for Infarct Size to Improve Preclinical Myocardial Infarction Small Animal Models |
| Q49821210 | Prognostic impact of unrecognized myocardial scar in the non-culprit territories by cardiac magnetic resonance imaging in patients with acute myocardial infarction |
| Q40742857 | Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study |
| Q34600002 | Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study |
| Q34216754 | Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T₁ mapping |
| Q38424924 | Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI. |
| Q35084600 | Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial |
| Q51407125 | Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study. |
| Q84356792 | Remodeling of the infarct territory in the time course of infarct healing in humans |
| Q47225590 | Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging |
| Q46407498 | Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent of area with late contrast MR enhancement. |
| Q60302167 | Selective infarct zone imaging with intravenous acoustically activated droplets |
| Q48273304 | Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain |
| Q40031259 | Serial and single time-point measurements of cardiac troponin T for prediction of clinical outcomes in patients with acute ST-segment elevation myocardial infarction |
| Q42829736 | Stem cells to repair the broken heart: much ado about nothing? |
| Q43506229 | T1 mapping in the rat myocardium at 7 tesla using a modified CINE inversion recovery sequence. |
| Q27014679 | The cardiac magnetic resonance (CMR) approach to assessing myocardial viability |
| Q37000804 | The effect of microvascular obstruction and intramyocardial hemorrhage on contractile recovery in reperfused myocardial infarction: insights from cardiovascular magnetic resonance |
| Q35666931 | Time elapsed after contrast injection is crucial to determine infarct transmurality and myocardial functional recovery after an acute myocardial infarction |
| Q38003826 | Troponin for the estimation of infarct size: what have we learned? |
| Q36172904 | Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction |
| Q34117708 | Troponin: the biomarker of choice for the detection of cardiac injury |
| Q87764241 | Uncommon cause of ST-segment elevation in V1-V3: incremental value of cardiac magnetic resonance imaging |
| Q48186587 | Use of two-dimensional speckle tracking echocardiography to predict cardiac events: Comparison of patients with acute myocardial infarction and chronic coronary artery disease. |
| Q30479106 | Usefulness of two-dimensional strain echocardiography to predict segmental viability following acute myocardial infarction and optimization using bayesian logistic spatial modeling |
| Q45876870 | Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction |
| Q58867648 | Why do we need magnetic resonance imaging in cardiology? |
Search more.